When will Medifast announce its financial results for the third quarter?

Medifast will announce its third quarter financial results on November 4, 2024, after market close.

What time is the conference call scheduled for?

The conference call to discuss the financial results is scheduled for 4:30 p.m. ET on the same day, November 4, 2024.

Who will be participating in the conference call?

Company participants for the conference call include Dan Chard, Chairman and CEO, and Jim Maloney, CFO of Medifast.

How can investors participate in the conference call?

Listeners can join the call by telephone at (201) 389-0879, with a playback available until November 11, 2024.

What key services does Medifast provide through its OPTAVIA program?

Medifast's holistic solution integrates lifestyle plans, scientifically developed products, and access to GLP-1 medications through a partnership with LifeMD.

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

10/21/24 4:05:00 PM ET

$LFMD

$MED

Medical/Nursing Services

Health Care

Packaged Foods

Consumer Staples

Get the next $LFMD alert in real time by email

Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

The conference call is scheduled to begin at 4:30 p.m. ET on November 4, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1691825&tp_key=981ddaa9cf and will be archived online and available through February 4, 2025. To join via telephone, listeners may dial (201) 389-0879.

A telephonic playback will be available from 8:30 p.m. ET, November 4, 2024, through November 11, 2024. Participants can dial (412) 317-6671 and enter access code 13749320 to hear the playback.

About Medifast®

Medifast (NYSE:MED) is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, which provides people with a simple yet comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA's holistic solution includes lifestyle plans with clinically proven health benefits, scientifically developed products, and a framework for habit creation – all reinforced by independent coach support for customers on their weight loss journeys. Through its collaboration with national virtual primary care provider LifeMD® (NASDAQ:LFMD) and its affiliated medical group, the holistic solution now includes access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature™. Visit the OPTAVIA and Medifast websites for more information and follow Medifast on X and LinkedIn.

MED-F

View source version on businesswire.com: https://www.businesswire.com/news/home/20241021465919/en/

Get the next $LFMD alert in real time by email

Recent Analyst Ratings for

$LFMD

$MED

Company	Date	Price Target	Rating	Analyst
MEDIFAST INC $MED	11/5/2024	$16.50 → $17.00	Underperform → Neutral	DA Davidson
LifeMD Inc. $LFMD	8/23/2024	$11.00	Buy	B. Riley Securities
MEDIFAST INC $MED	6/5/2024	$25.00 → $17.50	Neutral → Underperform	DA Davidson
LifeMD Inc. $LFMD	6/5/2024	$12.00	Overweight	KeyBanc Capital Markets
LifeMD Inc. $LFMD	11/30/2023	$10.00	Buy	Craig Hallum
MEDIFAST INC $MED	10/13/2023	$82.00	Equal-Weight	Stephens
LifeMD Inc. $LFMD	7/21/2023	$7.00	Overweight	Cantor Fitzgerald
LifeMD Inc. $LFMD	7/3/2023	$9.00	Buy	H.C. Wainwright

More analyst ratings

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Chat with this insight

Q&A

When will Medifast announce its financial results for the third quarter?

What time is the conference call scheduled for?

Who will be participating in the conference call?

How can investors participate in the conference call?

What key services does Medifast provide through its OPTAVIA program?

Recent Analyst Ratings for $LFMD$MED

$LFMD$MED Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Medifast upgraded by DA Davidson with a new price target

B. Riley Securities resumed coverage on LifeMD with a new price target

Medifast downgraded by DA Davidson with a new price target

$LFMD$MED Press Releases

Fastest customizable press release news feed in the world

LifeMD to Participate in Three Investor Conferences During November

Medifast Announces Third Quarter 2024 Financial Results

LifeMD® to Report Third Quarter 2024 Financial Results on November 7

$LFMD$MED SEC Filings

SEC Form 10-Q filed by LifeMD Inc.

SEC Form 10-Q filed by MEDIFAST INC

MEDIFAST INC filed SEC Form 8-K: Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits

$LFMD$MED Financials

Live finance-specific insights

Medifast Announces Third Quarter 2024 Financial Results

LifeMD® to Report Third Quarter 2024 Financial Results on November 7

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

$LFMD$MED Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

VP, Finance & CAO Mackenzie Jonathan Barrett covered exercise/tax liability with 11 shares, decreasing direct ownership by 0.28% to 3,906 units (SEC Form 4)

Chief Innovation Officer Galluppi Stefan bought $14,790 worth of shares (3,000 units at $4.93), increasing direct ownership by 7% to 45,449 units (SEC Form 4)

Chief Technology Officer Wijnker Dennis was granted 100,000 shares (SEC Form 4)

$LFMD$MED Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by LifeMD Inc.

Amendment: SEC Form SC 13G/A filed by MEDIFAST INC

SEC Form SC 13G filed by MEDIFAST INC

$LFMD$MED Market Insights

Live Market Insights

DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target

Keybanc Maintains Overweight on LifeMD, Lowers Price Target to $10

LifeMD Launches Commercial Health Insurance Acceptance For Its Primary Care Services, Including Weight Management

$LFMD$MED Leadership Updates

Live Leadership Updates

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

LifeMD Set to Join the Russell 3000 Index

LifeMD Appoints Dr. Calum MacRae to its Board of Directors

$LFMD$MED Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Innovation Officer Galluppi Stefan bought $14,790 worth of shares (3,000 units at $4.93), increasing direct ownership by 7% to 45,449 units (SEC Form 4)

Thomas Andrea B bought $3,471 worth of shares (50 units at $68.89), increasing direct ownership by 0.81% to 6,253 units (SEC Form 4)

Hoer Michael A. bought $3,428 worth of shares (50 units at $68.89), increasing direct ownership by 0.60% to 8,375 units (SEC Form 4)

Recent Analyst Ratings for
$LFMD
$MED

$LFMD
$MED
Analyst Ratings

$LFMD
$MED
Press Releases

$LFMD
$MED
SEC Filings

$LFMD
$MED
Financials

$LFMD
$MED
Insider Trading

$LFMD
$MED
Large Ownership Changes

$LFMD
$MED
Market Insights

$LFMD
$MED
Leadership Updates

$LFMD
$MED
Insider Purchases